# Drug Enforcement Administration — the long-form archive Everything Drug Enforcement Administration has published while this archive has been running: 26 documents across 7 days, oldest first. Coverage begins on 2026-08-11, which is when this archive started holding Federal Register issues — not when the agency started publishing. Anything earlier is absent from this page and its absence is not evidence. [HTML](https://downstream.sh/daily/agency/drug-enforcement-administration/archive.html) · [the last five days](https://downstream.sh/daily/agency/drug-enforcement-administration/index.md) ## 11 August 2026 — 1 document - **Proposed Rule** [Schedules of Controlled Substances: Rescheduling of Suvorexant, Lemborexant, and Daridorexant From Schedule IV Into Schedule V](https://www.federalregister.gov/documents/2026/08/11/2026-16375/schedules-of-controlled-substances-rescheduling-of-suvorexant-lemborexant-and-daridorexant-from) · `2026-16375` ## 12 August 2026 — 1 document > The Drug Enforcement Administration temporarily scheduled O-desmethyltramadol as a Schedule I controlled substance effective immediately. - **Rule** [Schedules of Controlled Substances: Temporary Placement of O-Desmethyltramadol in Schedule I](https://www.federalregister.gov/documents/2026/08/12/2026-16413/schedules-of-controlled-substances-temporary-placement-of-o-desmethyltramadol-in-schedule-i) · `2026-16413` ## 14 August 2026 — 1 document > The Drug Enforcement Administration published a notice on exempt chemical preparations under the Controlled Substances Act for applications received between March and June 2026. - **Notice** [Exempt Chemical Preparations Under the Controlled Substances Act](https://www.federalregister.gov/documents/2026/08/14/2026-16665/exempt-chemical-preparations-under-the-controlled-substances-act) · `2026-16665` ## 25 August 2026 — 12 documents > The Drug Enforcement Administration published twelve notices regarding controlled substance registration applications and one decision and order. - **Notice** [Bulk Manufacturer of Controlled Substances Application: Kinetochem LLC](https://www.federalregister.gov/documents/2026/08/25/2026-17288/bulk-manufacturer-of-controlled-substances-application-kinetochem-llc) · `2026-17288` - **Notice** [Bulk Manufacturer of Controlled Substances Application: Chattem Chemicals](https://www.federalregister.gov/documents/2026/08/25/2026-17287/bulk-manufacturer-of-controlled-substances-application-chattem-chemicals) · `2026-17287` - **Notice** [Importer of Controlled Substances Application: Chattem Chemicals](https://www.federalregister.gov/documents/2026/08/25/2026-17286/importer-of-controlled-substances-application-chattem-chemicals) · `2026-17286` - **Notice** [Importer of Controlled Substances Application: Prof Compounding CTS of Ameri](https://www.federalregister.gov/documents/2026/08/25/2026-17285/importer-of-controlled-substances-application-prof-compounding-cts-of-ameri) · `2026-17285` - **Notice** [Importer of Controlled Substances Application: Galephar Pharmaceutical Research Inc.](https://www.federalregister.gov/documents/2026/08/25/2026-17284/importer-of-controlled-substances-application-galephar-pharmaceutical-research-inc) · `2026-17284` - **Notice** [Bulk Manufacturer of Controlled Substances Application: Scottsdale Research Institute SRI Montana Satellite Laboratory](https://www.federalregister.gov/documents/2026/08/25/2026-17282/bulk-manufacturer-of-controlled-substances-application-scottsdale-research-institute-sri-montana) · `2026-17282` - **Notice** [Bulk Manufacturer of Controlled Substances Application: Curia Missouri Inc.](https://www.federalregister.gov/documents/2026/08/25/2026-17280/bulk-manufacturer-of-controlled-substances-application-curia-missouri-inc) · `2026-17280` - **Notice** [Importer of Controlled Substances Application: Vici Health Sciences, LLC](https://www.federalregister.gov/documents/2026/08/25/2026-17277/importer-of-controlled-substances-application-vici-health-sciences-llc) · `2026-17277` - **Notice** [Importer of Controlled Substances Application: Biopharmaceutical Research Company](https://www.federalregister.gov/documents/2026/08/25/2026-17276/importer-of-controlled-substances-application-biopharmaceutical-research-company) · `2026-17276` - **Notice** [Catina Allen, N.P.; Decision and Order](https://www.federalregister.gov/documents/2026/08/25/2026-17275/catina-allen-np-decision-and-order) · `2026-17275` - **Notice** [Bulk Manufacturer of Controlled Substances Application: Curia New York Inc](https://www.federalregister.gov/documents/2026/08/25/2026-17274/bulk-manufacturer-of-controlled-substances-application-curia-new-york-inc) · `2026-17274` - **Notice** [Bulk Manufacturer of Controlled Substances Application: Biopharmaceutical Research Company](https://www.federalregister.gov/documents/2026/08/25/2026-17273/bulk-manufacturer-of-controlled-substances-application-biopharmaceutical-research-company) · `2026-17273` ## 26 August 2026 — 6 documents > The DEA temporarily placed mitragynine pseudoindoxyl, MGM-15, and MGM-16 in Schedule I of the Controlled Substances Act. - **Rule** [Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I](https://www.federalregister.gov/documents/2026/08/26/2026-17429/schedules-of-controlled-substances-temporary-placement-of-mitragynine-pseudoindoxyl-mgm-15-and) · `2026-17429` - **Notice** [Importer of Controlled Substances Application: Curia New York Inc.](https://www.federalregister.gov/documents/2026/08/26/2026-17388/importer-of-controlled-substances-application-curia-new-york-inc) · `2026-17388` - **Notice** [Bulk Manufacturer of Controlled Substances Application: Cambrex Charles City](https://www.federalregister.gov/documents/2026/08/26/2026-17387/bulk-manufacturer-of-controlled-substances-application-cambrex-charles-city) · `2026-17387` - **Notice** [Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC](https://www.federalregister.gov/documents/2026/08/26/2026-17386/bulk-manufacturer-of-controlled-substances-application-chemtos-llc) · `2026-17386` - **Notice** [Importer of Controlled Substances Application: Experic LLC](https://www.federalregister.gov/documents/2026/08/26/2026-17385/importer-of-controlled-substances-application-experic-llc) · `2026-17385` - **Notice** [Importer of Controlled Substances Application: Cambrex Charles City](https://www.federalregister.gov/documents/2026/08/26/2026-17383/importer-of-controlled-substances-application-cambrex-charles-city) · `2026-17383` ## 27 August 2026 — 2 documents > The Drug Enforcement Administration placed cipepofol in Schedule IV and temporarily placed four synthetic opioid analogues in Schedule I of the Controlled Substances Act. - **Rule** [Schedules of Controlled Substances: Placement of Cipepofol in Schedule IV](https://www.federalregister.gov/documents/2026/08/27/2026-17536/schedules-of-controlled-substances-placement-of-cipepofol-in-schedule-iv) · `2026-17536` - **Rule** [Schedules of Controlled Substances: Temporary Placement of 5,6-Dichloro Brorphine, 5,6-Dichloro Desmethylchlorphine, N-Propionitrile Chlorphine, and Spirochlorphine in Schedule I of the Controlled Substances Act](https://www.federalregister.gov/documents/2026/08/27/2026-17531/schedules-of-controlled-substances-temporary-placement-of-56-dichloro-brorphine-56-dichloro) · `2026-17531` ## 28 August 2026 — 3 documents > The Drug Enforcement Administration published three decision and order notices regarding Atlantic Treatment Center, Thomas Earley, and Leila Kump. - **Notice** [Atlantic Treatment Center, LLC; Decision and Order](https://www.federalregister.gov/documents/2026/08/28/2026-17594/atlantic-treatment-center-llc-decision-and-order) · `2026-17594` - **Notice** [Thomas Earley, D.D.S.; Decision and Order](https://www.federalregister.gov/documents/2026/08/28/2026-17592/thomas-earley-dds-decision-and-order) · `2026-17592` - **Notice** [Leila Kump, M.D.; Decision and Order](https://www.federalregister.gov/documents/2026/08/28/2026-17589/leila-kump-md-decision-and-order) · `2026-17589` ## Ask an assistant instead Everything on this page is also a tool call. Add `mcp.downstream.sh` as an MCP server — no key, no account — then paste this: ``` Using the Downstream MCP server at mcp.downstream.sh, call whats_new_since with agency "Drug Enforcement Administration" since 2026-08-11, then tell me what this agency has been working on and which of its deadlines are still open. ``` Reaches `whats_new_since`. The response carries its own citations and states what it is missing, including which dates it has no record for. --- Every document linked here is a work of the United States government and in the public domain. The Federal Register's HTML and XML renderings are unofficial; the PDF on each item is the official text, and that is the one to cite. Counts are arithmetic over published fields, dates are printed as filed, and titles are verbatim. Where we have nothing, this says nothing rather than estimating. The one-sentence agency summaries are machine-written from those same fields and are labelled where they appear. [Downstream](https://downstream.sh/) · [the essay](https://downstream.sh/essays/a-country-that-can-see.html) · [the daily issue](https://downstream.sh/daily/) · [MCP endpoint](https://mcp.downstream.sh)